Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Black M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337.
Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19:133–43.
Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoğlu L, Lewis EF. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56.
Echouffo-Tcheugui JB, Ndumele CE, Zhang S, Florido R, Matsushita K, Coresh J, Skali H, Shah AM, Selvin E. Diabetes and progression of heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2022;79:2285–93.
Article CAS PubMed PubMed Central Google Scholar
Ohkuma T, Komorita Y, Peters SAE, Woodward M. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62:1550–60.
Article PubMed PubMed Central Google Scholar
Aune D, Schlesinger S, Neuenschwander M, Feng T, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of heart failure: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2018;28:1081–91.
Article CAS PubMed Google Scholar
Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the american heart association and the heart failure society of america: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019;140:e294–324.
Article CAS PubMed Google Scholar
Doran AC, Yurdagul A, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20:254–67.
Article CAS PubMed Google Scholar
Gerlach BD, Ampomah PB, Yurdagul A, Liu C, Lauring MC, Wang X, Kasikara C, Kong N, Shi J, Tao W, Tabas I. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 2021;33:2445-2463.e2448.
Article CAS PubMed PubMed Central Google Scholar
Tao H, Yancey PG, Babaev VR, Blakemore JL, Zhang Y, Ding L, Fazio S, Linton MF. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis. J Lipid Res. 2015;56:1449–60.
Article CAS PubMed PubMed Central Google Scholar
Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol. 2008;28:1421–8.
Article CAS PubMed PubMed Central Google Scholar
Zhang S, Weinberg S, DeBerge M, Gainullina A, Schipma M, Kinchen JM, Ben-Sahra I, Gius DR, Yvan-Charvet L, Chandel NS, et al. Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Metab. 2019;29:443-456.e445.
Article CAS PubMed Google Scholar
Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science. 2013;341:403–6.
Article CAS PubMed Google Scholar
Trzeciak A, Wang YT, Perry JSA. First we eat, then we do everything else: the dynamic metabolic regulation of efferocytosis. Cell Metab. 2021;33:2126–41.
Article CAS PubMed PubMed Central Google Scholar
Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21:398–414.
Article CAS PubMed PubMed Central Google Scholar
Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G, Tabas I. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest. 2017;127:564–8.
Article PubMed PubMed Central Google Scholar
Fourgeaud L, Través PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, Callaway P, Zagórska A, Rothlin CV, Nimmerjahn A, Lemke G. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532:240–4.
Article CAS PubMed PubMed Central Google Scholar
Bosurgi L, Cao YG, Cabeza-Cabrerizo M, Tucci A, Hughes LD, Kong Y, Weinstein JS, Licona-Limon P, Schmid ET, Pelorosso F, et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 2017;356:1072–6.
Article CAS PubMed PubMed Central Google Scholar
Huang R, Zhang L, Li X, Liu F, Cheng X, Ran H, Wang Z, Li Y, Feng Y, Liang L, et al. Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy. J Control Release. 2023;356:610–22.
Article CAS PubMed Google Scholar
Li X, Yuan P, Yang H, Zong X, Yang C, Chen X, Li Y, Yan X, Wen Y, Zhu T, et al. Virus-like nanotherapeutic for spatiotemporally enhancing antigen presentation and cross-presentation toward potential personalized immunotherapy. Adv Healthc Mater. 2023;1:e2300921.
Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11:164–80.
Article CAS PubMed PubMed Central Google Scholar
Liam-Or R, Faruqu FN, Walters A, Han S, Xu L, Wang JT, Oberlaender J, Sanchez-Fueyo A, Lombardi G, Dazzi F, et al: Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nat Nanotechnol 2024.
Sun L, Zhang M, Shi Y, Fang L, Cao F. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater. 2022;141:164–77.
Article CAS PubMed Google Scholar
Yang L, Patel KD, Rathnam C, Thangam R, Hou Y, Kang H, Lee KB. Harnessing the therapeutic potential of extracellular vesicles for biomedical applications using multifunctional magnetic nanomaterials. Small. 2022;18: e2104783.
Article PubMed PubMed Central Google Scholar
Zhao Y, Nie Z, Hong H, Qiu X, Han S, Yu Y, Liu M, Qiu X, Liu K, Meng S, et al. Spectroscopic visualization and phase manipulation of chiral charge density waves in 1T-TaS2. Nat Commun. 2023;14:2223.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Yu D, Liu S, Liu C, Liu Z, Ren J, Qu X. NIR-II Hydrogen-Bonded Organic Frameworks (HOFs) used for target-specific amyloid-β photooxygenation in an alzheimer’s disease model. Angew Chem Int Ed Engl. 2022;61:e202109068.
Article CAS PubMed Google Scholar
Brinck J, Hagström E, Nåtman J, Franzén S, Eeg-Olofsson K, Nathanson D, Eliasson B. Cardiovascular outcomes in patients with both diabetes and phenotypic familial hypercholesterolemia: a nationwide register-based cohort study. Diabetes Care. 2022;45:3040–9.
Article CAS PubMed PubMed Central Google Scholar
García-Carro C, Vergara A, Agraz I, Jacobs-Cachá C, Espinel E, Seron D, Soler MJ. The new era for reno-cardiovascular treatment in type 2 diabetes. J Clin Med. 2019;8:1.
Li Y, Cui R, Liu K, Eshak ES, Cui M, Dong J, Imano H, Muraki I, Kiyama M, Kitamura A, et al. Relationship between endothelial dysfunction and prevalence of chronic kidney disease: the circulatory risk in communities study (CIRCS). J Atheroscler Thromb. 2021;28:622–9.
Article CAS PubMed Google Scholar
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21:1.
Capodanno D, Angiolillo DJ. Antithrombotic therapy for atherosclerotic cardiovascular disease risk mitigation in patients with coronary artery disease and diabetes mellitus. Circulation. 2020;142:2172–88.
Article CAS PubMed Google Scholar
Wu Y, Zou H. Research progress on mitochondrial dysfunction in diabetic retinopathy. Antioxidants (Basel). 2022;11:1.
Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524–33.
Article CAS PubMed Google Scholar
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995–2008.
Article CAS PubMed Google Scholar
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834–44.
留言 (0)